Lb Pharmaceuticals (LBRX) Invested Capital (2024 - 2026)

Lb Pharmaceuticals' Invested Capital history runs 3 years deep, the most recent figure standing at $379.8 million for Q1 2026.

• In Q1 2026, Invested Capital rose 482.37% year-over-year to $379.8 million; the TTM figure through Mar 2026 stood at $379.8 million (up 482.37% YoY), while the FY2025 annual figure was $302.7 million, up 428.79% from the prior year.
• Invested Capital was $379.8 million for Q1 2026 at Lb Pharmaceuticals, up from $302.7 million in the prior quarter.
• In the past five years, Invested Capital ranged from a high of $379.8 million in Q1 2026 to a low of -$99.3 million in Q1 2025.
• Historically, Invested Capital has averaged $118.5 million across 3 years, with a median of $105.6 million in 2024.
• The sharpest annual moves came in 2025 and 2026: Invested Capital jumped 428.79% in 2025, then jumped 482.37% in 2026.
• A 3-year view of Invested Capital shows it stood at -$92.0 million in 2024, then surged by 428.79% to $302.7 million in 2025, then climbed by 25.5% to $379.8 million in 2026.
• The last three Invested Capital figures came in at $379.8 million (Q1 2026), $302.7 million (Q4 2025), and $311.2 million (Q3 2025), per Business Quant data.